Expression Profiling of Placentomegaly Associated with Nuclear Transplantation of Mouse ES Cells  by Suemizu, Hiroshi et al.
Developmental Biology 253, 36–53 (2003)
doi:10.1006/dbio.2002.0870Expression Profiling of Placentomegaly Associated
with Nuclear Transplantation of Mouse ES Cells
Hiroshi Suemizu,* ,† Kazuhiro Aiba,* Toshiyuki Yoshikawa,*
Alexei A. Sharov,* Nobuhiro Shimozawa,†
Norikazu Tamaoki,† and Minoru S. H. Ko* ,1
*Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on
Aging, NIH, Baltimore, Maryland 21224; and †Central Institute for Experimental Animals,
Miyamae, Kawasaki 216-0001, Japan
Transplantation of nuclei (NT) from engineered mouse ES cells is a potentially powerful and rapid route to create knockout
mice, obviating the need for matings to obtain germ-line chimeras. However, such an application is currently impossible,
because NT often results in abnormalities in embryo and placenta. Although the epigenetic instability of several imprinted
genes in ES cells and ES-derived NT mice has been demonstrated, it is not clear yet what causes the abnormalities. To gain
perspective on the extent and types of changes, we have done gene expression profiling for mouse placentas produced by NT
of ES cells and compared them with the expression profiles of placentas produced by NT of one-cell embryos. Based on
microarray studies with the NIA 15K mouse cDNA collection, we report five principal aberrant events: (1) inappropriate
expression of imprinted genes; (2) altered expression of regulatory genes involved in global gene expression, such as DNA
methyltransferase and histone acetyltransferase; (3) increased expression of oncogenes and growth promoting genes; (4)
overexpression of genes involved in placental growth, such as Plac1; and (5) identification of many novel genes
overexpressed in ES-derived NT mouse placentas, including Pitrm1, a new member of the metalloprotease family. The
results indicate that placentomegaly in ES-derived NT mice is associated with large-scale dysregulation of normal gene
expression patterns. The study also suggests the presence of two regulatory pathways that may lead to histologically
discernable placentomegaly. The discovery of groups of genes with altered expression may provide potential targets for
intervention to mimic natural regulation more faithfully in NT mice. © 2003 Elsevier Science (USA)
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Genomic totipotency of differentiated somatic cells has
been studied for more than a century in a variety of species
(reviewed in Di Berardino, 1997). In mammals, since the
first report of cloning of sheep by the nuclear transplanta-
tion (NT) of a somatic cell nucleus to an enucleated
unfertilized egg (Wilmut et al., 1997), animal cloning tech-
nology has been successfully adapted to other species (re-
viewed in Ogura et al., 2001; Rideout et al., 2001). Success-
ful animal cloning requires appropriate reprogramming of
donor nuclei from a committed to totipotent state by
unknown factors present in oocytes (Baguisi et al., 1999;
136Kato et al., 1998; Onishi et al., 2000; Polejaeva et al., 2000;
Wakayama et al., 1998; Wilmut et al., 1997). This process
has thus far been variable and inefficient, with only a few
percent of the nuclear transferred embryos developing to
term (Wakayama and Yanagimachi, 1999). Even animals
that survive to birth often show abnormalities, particularly
an overgrowth phenotype called “large offspring syndrome”
(Young et al., 1998). In the case of livestock animals, even
in vitro embryo culture can be sufficient to cause this
syndrome (Young et al., 1998), which has been recently
considered to result from reduced expression of IGF2R
(Young et al., 2001).
In vitro embryo culture alone does not usually cause
“large offspring syndrome” for mice, but the animals gen-
erated by NT of somatic nuclei are often born with abnor-To whom correspondence should be addressed. Fax: (410) 558-
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megaly”) (Ono et al., 2001; Wakayama and Yanagimachi,
1999) and birth weight (Eggan et al., 2001). A recent report
also shows that somatic cell-derived NT mice also have a
shorter life span (Ogonuki et al., 2002). It has been conjec-
tured that inappropriate reprogramming of somatic nuclei
to a totipotent state is a major cause of abnormal develop-
ment in NT animals (Wakayama and Yanagimachi, 1999).
As summarized recently (Rideout et al., 2001), several
studies have indicated that nuclear transfer into an unfer-
tilized egg does not always appropriately reprogram epige-
netic information impressed on the somatic nucleus. How-
ever, investigations have thus far been limited to analyses
of several imprinted (Humpherys et al., 2001) or develop-
mental genes (Daniels et al., 2000), as well as the methyl-
ation status of genomic DNA (Kang et al., 2001; Ohgane et
al., 2001) or X chromosome inactivation (Eggan et al., 2000).
In addition to the value of NT mice as a model to study
the mechanism of nuclear reprogramming in general, a very
useful application of NT technology is the direct creation of
mouse from the knockout ES cells (Wakayama et al., 1999).
Although the aggregation of knockout ES cells with tet-
raploid blastocysts has been successfully used for such a
purpose (Nagy et al., 1993), ES cells tend to lose this ability
after extensive manipulation and/or long-term in vitro
culture. As a result, the application of this technology is
somewhat limited. NT technology could offer an ideal
route if the abnormalities often associated with it can be
reduced or prevented.
To gain perspective on the extent and range of changes,
we have carried out gene expression profiling on NT mouse
placentas by using the NIA 15K mouse cDNA microarray
(Kargul et al., 2001; Tanaka et al., 2000). This array consists
of approximately 12,000 unique mouse genes, enriched for
genes expressed in early mouse embryos, including preim-
plantation development, and placental tissues. It is thus
well adapted to this study.
MATERIALS AND METHODS
Preparation of Cloned Mice
Cloned mice were produced by the single nuclear transfer
method (Ono et al., 2001; described in detail in Shimozawa et al.,
2002). In brief, the TT2 ES cell line (Yagi et al., 1993), derived from
a male B6CBF1 (C57BL/6N Crj  CBA/JN Crj) embryo, was
targeted with the mouse oviduct-specific glycoprotein (OGP) gene.
Neither OGP/ nor OGP/ mice derived from the ES cells showed
any abnormalities (Shimozawa et al., 2002). The nucleus of a single
metaphase arrested ES cell was transferred into an enucleated
unfertilized oocyte (B6CBF1: C57BL/6Cr SlcCBA/N Slc), and the
oocytes were then artificially activated with 10 mM SrCl2 for 6 h.
Embryos that developed to the morula/blastocyst stage were trans-
ferred into the uteri of day 3 pseudopregnant MCH (ICR) females.
Control mice were produced by the same procedure, using in vitro
fertilized [B6CBF1 (C57BL/6N Crj  CBA/JN Crj)] one-cell nuclei
as nuclear donors. Live-born pups and their placentas were col-
lected at 19.5 days postcoitum (dpc) by Caesarean section.
Although both donor and recipient were derived from B6CBF1,
we were able to distinguish the donor (C57BL/6N Crj  CBA/JN
Crj) from the recipient nucleus (C57BL/6Cr Slc  CBA/N Slc) by
subline differences of microsatellite markers (Shimozawa et al.,
2002). The success rates for each step of NT procedure were as
follows: of 745 fused oocytes, 587 oocytes were activated normally
(78.8%); of 587 cultured oocytes, 356 embryos were developed to
morula/blastocyst stage (60.6%); 313 morulae/blastocysts were
transferred to 28 recipients (53.3%); of 28 recipients, 17 became
pregnant (60.7%); and 11 live pups were born (1.9%) (Shimozawa et
al., 2002).
Because only a small fraction of morulae/blastocysts that were
transferred to uterus develop to term, the litter size of ES-derived
NT mice was small (up to three). To minimize the possible effects
of small litter size on the size of placenta and embryo, only four to
six blastocysts from one-cell-derived NT were transferred to the
uterus, so that the litter size for the control was again less than or
equal to three. In our hands, control one-cell-derived NTs did not
develop placentomegaly.
Microarray Analyses
Total RNAs were prepared from placentas of two live-born
ES-derived NT mice and a pool of five live-born one-cell-derived
NT (control) mice. [33P]-labeled cDNAs from each sample were
hybridized in triplicate on NIA mouse 15K microarrays (Tanaka et
al., 2000). About one-half of the genes are novel, with about 90%
sequence-verified (Kargul et al., 2001). Although the sequence-
unverified clones most likely have correct gene identifications
(Kargul et al., 2001), for clarity, only sequence-verified clones are
used for the analysis in this paper. Hybridizations and data analyses
were carried out as previously described (Tanaka et al., 2000). In
brief, hybridization images were acquired with a STORM860
PhosphorImager (Amersham Pharmacia). Signal intensities of indi-
vidual spots were obtained with overlaid grids. Background signal
intensities were obtained from areas where no DNA was spotted.
FIG. 1. Mean square error estimated using 2-factor ANOVA
without replication and then averaged over 100 genes with similar
expression levels is shown against the gene rank (genes were sorted
by decreasing log-average expression).
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Statistical Analyses
Pearson’s Correlation Coefficients among triplicates indicate the
high reproducibility of the expression data (0.92, 0.95, and 0.99 for
control one-cell-derived NT placentas; 0.97, 0.98, and 0.99 for
ES-derived NT placenta #1; and 0.97, 0.98, and 0.99 for ES-derived
NT placenta #2).
Two-factor ANOVA without replications was used to identify
genes differentially expressed in a statistically significant manner
between ES-derived NT placenta #1, ES-derived NT placenta #2,
and a pool of five one-cell-derived NT placentas. Gene expression
intensity was log-transformed prior to the analysis. Genes were
sorted by decreasing average log-expression, and then the mean
square error was averaged for each 100 genes in the list. The average
mean square error was low for well-expressed genes but increased
for genes with log-expression  5 (Fig. 1). Although data with
expression 105 are variable, it still may be useful for comparison
of ES-derived NT mice with control one-cell-derived NT mice.
Thus, we set the detection threshold at a lower level of 10,000 and
replaced all values 10,000 with 10,000. Then, ANOVA was
reestimated with adjusted values. Because the use of the lower
limit of 10,000 for the data may reduce the variability and result in
spurious significant effects, we used the original mean square error
for mean comparison (see below). The sample size was not suffi-
cient to distinguish between genes with a highly variable and stable
expression among genes with similar average expression. Thus, for
comparison of means, we used a t-test based on the average mean
square error in 100 genes with similar average expression level:
t 
Mi  Mj
MSE1/ni  1/nj ,
where Mi is the average expression for each kind of placenta i, ni is
the number of replications, and MSE is the average mean square
error (Fig. 1).
Nonadjusted P-values estimated from the t-distribution cannot
be used for determining statistical significance. Even if the null-
hypothesis is true for all the genes (i.e., means are equal in the
experiment and control), then 5% of genes will erroneously appear
significant. To apply a more stringent statistical test, we used two
kinds of P-adjustment: (1) the Bonferroni correction, which ensures
no false rejection of the null hypothesis with a 0.95 probability, and
(2) the False Discovery Rate (FDR) rule, which ensures that the
proportion of erroneously detected genes with differential expres-
sion levels is equal to a particular value (Benjamini and Hochberg,
1995). In this study, we use FDR  0.05. The Bonferroni correction
is PN, where P is the original error probability estimated from the
t-distribution and N  15,247 is the number of genes tested. The
FDR correction is PN/k where k is the rank of the gene sorted by a
decreasing t-value (Benjamini and Hochberg, 1995).
FIG. 2. Histological examination of control and ES-derived NT placenta stained with hematoxylin/eosin. (a) Size difference between
control placenta and ES-derived NT placenta. Sections were made after removing deciduas. (b) High-magnification view of spongiotropho-
blast layer and labyrinth layer of control placenta. (c) High magnification view of a portion close to maternal component, and (d) middle
portion in ES-derived NT placenta. L, labyrinthine trophoblast cells; S, spongiotrophoblast cells; G, glycogen cells. Scale bars, 1 mm (a) and
100 m (b–d).
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FIG. 3. Expression profiling of genes between control and NT mice placenta. (a–c) Average log-expression levels of three independent
hybridizations for each gene were displayed on scatter plots. Genes showing significantly different expression levels between control,
cloned mouse #1, and cloned mouse #2, at the 5% confidence level (PN  0.05, Student’s t-test with Bonferroni correction) are displayed
as black triangles; genes that satisfy the condition FDR  0.05 but do not satisfy the Bonferroni correction are displayed as empty squares;
other genes are displayed as gray spots. Diagonal lines indicate twofold expression differences. Three spots (A–C) selected in (b) and (c) show
marked differences in gene expression level, and corresponding spots in plots (b) and (c) indicate the same clones.
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RT-PCR Analysis
For RT-PCR analysis, 3 g of total RNA was used as template for
synthesizing the complementary DNAs with an oligo(dT) primer
and the GeneAmp RNA PCR Kit (Applera Corporation, Applied
Biosystems, Foster City, CA) according to the manufacturer’s
instructions. Thermal cycling conditions were as follows: 94°C, 2
min followed by 21, 23, 25, 27, 29, 31, 33, 35, and 37 cycles of 94°C,
30 s; 58–66°C, 30 s; 72°C, 60 s; 72°C, 2 min. PCR products were
separated by electrophoresis on a 3% Agarose (Nusieve 3:1) gel and
then stained with ethidium bromide (0.25 mg/ml). DNA bands
were photographed under UV light. Primer sequences and anneal-
ing temperatures used for this experiments are shown in Table 1.
RESULTS AND DISCUSSION
Production of NT Placentas
We produced NT mice by the single nucleus transfer
method (Ono et al., 2001), using oviduct-specific glycopro-
tein (OGP)-targeted TT2 ES cells (B6CBF1: male cells with
XY karyotypes and OGP/) as nuclear donors, enucleated
B6CBF1 oocytes as recipients, and pseudopregnant MCH
(ICR) females as surrogate mothers (Shimozawa et al.,
2002). The OGP-targeted ES cells were used as representa-
tive knockout ES cells, but neither heterozygous nor ho-
mozygous OGP knockout mice showed any abnormalities
(Shimozawa et al., 2002), and thus it is very unlikely that
the abnormalities observed in the ES-derived NT mice were
caused by the half-dose of the OGP gene. Control mice were
produced by the same NT method, using in vitro fertilized
B6CBF1 one-cell nuclei as nuclear donors and enucleated
B6CBF1 eggs as recipients. In other words, the current
experiment examines the differences between the use of
pluripotent donor nuclei from cultured ES cells and the use
of totipotent donor nuclei from one-cell embryos. The use
of the one-cell-derived NT mice as control excludes other
factors that may also affect the NT mouse, such as the
culture conditions of preimplantation embryos, which
alone can induce large offspring syndrome in sheep and
cattle (Young et al., 2001), and the NT procedure itself.
Live-born pups and their placentas were collected at 19.5
dpc by Caesarean section. Placentas of ES-derived NT mice
were much heavier (0.49  0.18 g, n  11) than the
placentas of one-cell-derived NT mice (0.12  0.1 g, n  7)
(Shimozawa et al., 2002). Because about 50.0% of one-cell-
derived NT embryos survived to term, and both pups and
placentas were always normal in size (Shimozawa et al.,
2002), it is clear that the placentomegaly was not caused by
the NT procedure itself, but most likely resulted from the
status of donor nuclei from ES cells.
Total RNAs were purified from each of the three largest
placentas (ES-derived NT placenta #1, 0.80 g; ES-derived
NT placenta #2, 0.60 g; and ES-derived NT placenta #3,
0.75 g). Total RNAs were also purified from seven placentas
produced by the NT of one-cell embryo (one-cell-derived
NT #1–7). ES-derived NT pup #1 (1.51 g) died 30 min after
Caesarean section, and ES-derived NT pup #3 (2.27 g) was
cannibalized by his foster mother, but ES-derived NT pup
#2 (2.25 g) has now survived more than 1 year. These pups
were larger than normal.
Histological Analyses of Placentas
It has been reported that essentially all NT placentas are
larger than normal (Eggan et al., 2001; Ono et al., 2001;
Rideout et al., 2001; Tanaka et al., 2001; Wakayama et al.,
1999; Wakayama and Yanagimachi, 1999). As exemplified
in Fig. 2a, all ES-derived NT placentas in this report were
larger than one-cell-derived NT placentas. Detailed exami-
nation of one-cell-derived NT placenta revealed character-
istic features of normal placenta, including distinctive
layers of decidua, spongiotrophoblast, and labyrinth, ar-
ranged in a gradient manner (Fig. 2b). In sharp contrast,
ES-derived NT placenta showed a number of abnormal
features: (1) an expanded glycogen cell layer on the decidua
side (Fig. 2c); (2) the enlargement of the spongiotrophoblast
layer, but not the labyrinth layer (Fig. 2d); and (3) deep
invagination of spongiotrophoblast layers into labyrinth,
and the loss of a clear demarcation between these two
layers (Fig. 2d). Many spindle-shaped spongiotrophoblast
TABLE 1
A List of Primers Used for RT-PCR Analyses
Target genes
Primer sequences Annealing
temperature
(°C)
Expected
size
(bp)Forward Reverse
H19 5	-ccacccctgagaatccatcttc-3	 5	-ccaaaccagtgcaatcgacttagtg-3	 63.0 256
Plac1 5	-cttccaagggctcatcaacg-3	 5	-tggcatctatttggctgacagtag-3	 63.0 419
Adm 5	-cgaggaacgtgcaatgcttg-3	 5	-gataatcaggcgctctccacc-3	 64.0 276
Pem 5	-aggaacaaaatgagccagttgctg-3	 5	-aagcaggacactcgaatgttcctc-3	 63.0 302
Igf2 5	-ctcagcaagtgcctaaagaatgggc-3	 5	-ggtgacatatggcgttcgacgc-3	 63.0 393
Igf2r 5	-ccaagcacctccaaccaaataag-3	 5	-ccctctgttgtgagatgcatgtg-3	 63.0 286
Dnmt1 5	-cttcgtgtcctacagacgctcc-3	 5	-ctaacaaacttcttgtcatccaccac-3	 62.2 248
Dnmt3a 5	-cacaaacaggaagagaatagagacc-3	 5	-gaagtcgggatgtacagtagttaacag-3	 60.0 300
Dnmt3b 5	-cccgttcgacttggtgattgg-3	 5	-catcgatcatcactgggttacatgc-3	 66.0 250
H3002E07 5	-ctccagtcttttgggaaagc-3	 5	-agctcagaggctcagctgtt-3	 60.4 389
40 Suemizu et al.
© 2003 Elsevier Science (USA). All rights reserved.
cells were dispersed deep in the labyrinth layer (Fig. 2d).
These results confirmed the previous results observing the
similar pathology in cumulus-cell-derived NT placentas
(Tanaka et al., 2001) and fibroblast-derived NT mice (Ono
et al., 2001).
Global Gene Expression Analyses by cDNA
Microarrays
To provide enough RNA for hybridizations, five one-cell-
derived NT placentas had to be pooled, whereas ES-derived
NT placentas #1 and #2 provided enough RNA to be
processed separately. 33P-labeled cDNAs synthesized from
each sample were hybridized separately to NIA mouse 15K
cDNA microarrays (Tanaka et al., 2000). To minimize the
technical variability of microarray analyses and to obtain
statistically valid gene expression data, we carried out
hybridizations in triplicate for each sample, and thereby
generated 
137,000 data points. Two-factor ANOVA with-
out replication was used to identify genes differentially
expressed in a statistically significant manner between
ES-derived NT placenta #1, ES-derived NT placenta #2, and
a pool of five one-cell-derived NT placentas (see Materials
and Methods).
FIG. 4. Semiquantitative RT-PCR analyses. (a) Imprinted genes. (b) DNA methyltransferases. (c) Placenta-specific genes. (d) Pitrm1.
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Previous reports showed significant variability for the
expression levels of several imprinted genes among ES-
derived NT mice (Humpherys et al., 2001). Therefore, we
first examined the expression differences between two
ES-derived NT placentas (Fig. 3a). Because nonadjusted
P-values estimated from the t-distribution cannot in gen-
eral be used to determine statistical significance, we used
two kinds of P-adjustment: the Bonferroni correction and
False Discovery Rate (FDR) rule (see Materials and Methods
for detail). With neither the Bonferroni correction nor FDR,
none of the genes showed a significant difference in expres-
sion. Although only two ES-derived NT placentas were
examined here, the remarkable overall similarity between
them suggests that consistent gene expression changes
caused the placentomegaly associated with NT.
In contrast, both ES-derived NT placentas showed signifi-
cant and consistent differences to the control placentas
(Figs. 3b and 3c). The number of genes with statistically
proven differential expression was similar between the two
ES-derived NT placentas (Table 2). The lists of genes for
ES-derived NT placentas #1 and #2 substantially over-
lapped. The index of similarity, 2N12/(N1  N2), where N1
and N2 are the number of genes in each list and N12 is the
number of common genes, was 0.87 for FDR  0.05, and
0.80 for Bonferroni-corrected P-values (Table 2). Of the
15,247 total feature sets present on this microarray, ES-
FIG. 5. Structures of new genes upregulated in ES-derived NT placenta. (a) Pitrm1 mRNA consists of 27 exons, which are shown as bars.
Red bars indicate exons missed in the annotation of Celera mouse genome sequence. (b) Comparison Pitrm1 with other homologous genes.
TABLE 2
Number of Genes with Differential Expression
Cloned
mouse #1
vs control
Cloned
mouse #2
vs control
Similarity
index
PN  0.05, 903 961 0.80
Bonferroni
FDR  0.05 2674 2832 0.87
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derived NT placenta #1 and #2 compared with a control
one-cell-derived NT placentas showed 1,807 and 1,964
genes with more than 2-fold statistically significant greater
expression (FDR  0.05) (Figs. 3b and 3c). Genes showing
statistically significant 2-fold expression differences in
both placentas #1 and #2 (PN  0.05, Bonferroni correction)
are listed in Tables 3 and 4 (for all the data, see Supplemen-
tal Table 1).
Imprinted Genes
The most profound reduction of expression levels in
ES-derived NT placentas was seen in the H19 imprinted
gene. Three (A–C) of the six most prominent spots that
show much lower expression in ES-derived NT placentas
than in control one-cell-derived NT placenta (Fig. 3b, c;
spots A–C) represent redundant cDNA clones for the H19
imprinted gene. (The majority of genes on this microarray
are unique, but H19 and some others are included multiple
times. These redundant genes serve as internal controls for
the reproducibility of the microarray data.) Consistent with
visual inspection, the H19 gene was at the top of the list for
ES-derived NT placentas (Table 3). Because it is also known
that H19 gene knockout mice exhibit placentomegaly (Eg-
genschwiler et al., 1997), the H19 gene is an intriguing
candidate as one cause for placentomegaly in ES-derived
NT placentas.
The gene dysregulation in the H19 knockout mice is
thought to act by the correlated overexpression of Igf2, the
adjacent imprinted gene (Eggenschwiler et al., 1997). Con-
sistent with that notion, the expression of Igf2 (cDNA clone
name: H3024B07) in ES-derived NT placentas was 4.1- to
4.8-fold higher than that in control one-cell-derived NT
placenta (Supplemental Table 1). In contrast, another im-
printed gene, Igf2 receptor (Igf2r: H3148G08), disruption of
which also leads to placentomegaly (Lau et al., 1994),
showed oppositely correlated expression, i.e., higher expres-
sion in ES-derived NT than in control placenta (3.0-fold in
ES-derived NT placenta #1 and 3.2-fold in ES-derived NT
placenta #2).
Further validation of microarray and extension of the
analysis to more NT mice was done by semiquantitative
RT-PCR analysis on the three samples used for cDNA
microarray analyses, and also on an additional ES-derived
NT placenta (#3) and two one-cell-derived NT placentas
(control #2 and #3) (Fig. 4). The H19 gene showed consistent
downregulation in all three ES-derived NT placentas com-
pared with three one-cell-derived NT placentas. On the
other hand, Igf2 and Igf2r showed more variation even
within control one-cell-derived placentas. This suggests
that changes of Igf2 and Igf2r levels observed in microarray
analysis are not associated with placentomegaly, but rather
with variation among placentas.
Recent extensive examination of several imprinted genes
(including H19 and Igf2 genes) in cloned mouse placentas
and pups also derived from ES cells has shown similar
dysregulation, but with a greater extent of variability of
expression levels among individual cloned mice (Humph-
erys et al., 2001). It was inferred that there is no strict
correlation between the expression level of imprinted genes
and overgrowth of placentas and pups (Humpherys et al.,
2001). Furthermore, it has recently been shown that com-
parable epigenetic instability of imprinted genes was ob-
served in ES-derived cloned mice, but not in cumulus
cell-derived cloned mice (Inoue et al., 2002). Our results
with Igf2 and Igf2r further support the notion that the
dysregulation of imprinted genes is not a likely primary
cause of placental defects; the reduction of H19 gene
expression observed could explain part but probably not all
of the placentomegaly in ES-derived NT mice.
Global Regulator of Gene Expressions
Because the susceptibility of imprinted genes to change
could be attributed to the secondary effect of an increased
level of genome-wide DNA methylation, dysregulation of
DNA methyltransferases may be key. Indeed, the microar-
ray analysis showed that de novo methyltransferase
Dnmt3a, which is important for mammalian development
(Okano et al., 1999), was upregulated in ES-derived NT
placentas (3.7- to 3.9-fold). Consistent with the microarray
results, semiquantitative RT-PCR for Dnmt1, Dnmt3a, and
Dnmt3b showed higher expression in three independent
ES-derived NT placentas (Fig. 4b). It has been shown that
overexpression of Dnmt1 in ES cells results in genomic
hypermethylation, downregulation of H19 expression, and
upregulation of Igf2 expression (Biniszkiewicz et al., 2002).
Opposite expression patterns of H19 and Igf2 have also been
observed in mice after the disruption of Dnmt1 (Li et al.,
1993) and aberrant methylation of repetitive DNAs has
been demonstrated in cloned mammalian embryos (Kang et
al., 2001; Ohgane et al., 2001). Overall, it is conceivable
that primary changes in ES-derived NT placentas result
from excessive methylation of genomic DNAs by overex-
pressed Dnmt1, Dnmt3a, and Dnmt3b, leading in turn to
secondary changes such as dysregulation of some imprinted
genes.
In addition to methylation/demethylation of genomic
DNAs, acetylation/deacetylation of the histone core gov-
erns much of global gene expression. We observed that
expression of histone acetyltransferase (H3107B07: mouse
ortholog of human HBO1; Iizuka and Stillman, 1999) was
3.3- and 3.4-fold higher in ES-derived NT placentas than
control placenta (Supplemental Table 1). Although the
direct involvement of this protein in transcriptional activa-
tion has not been shown, such an increase might lead to the
activation of a number of genes in the ES-derived NT
placenta. This could rationalize the finding that the major-
ity of genes with statistically significantly different levels
were more highly expressed in ES-derived NT placenta than
in control placenta (Figs. 3b and 3c). Interestingly, genes
overexpressed in ES-derived NT placentas include many
oncogenes and tumor-associated proteins, such as Ets2
(H3028G09: 11.1- and 10.9-fold), Ralb (H3094F12: 10.1- and
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10.5-fold), Jun (H3058C09: 3.1- and 2.4-fold), Ptov1
(H3083E01: 2.8- and 3.0-fold), Akt1 (H3020C06: 5.0- and
4.2-fold), Rab9 (H3102H06: 5.0- and 5.9-fold), and Rab14
(H3137C05: 2.1- and 2.7-fold). ES-derived NT placentas
thus have shown tumor-like expression patterns, consistent
with their extreme overgrowth phenotype.
Placenta-Specific Genes
Another conspicuous feature of ES-derived NT placentas
was the increased expression of trophoblast-expressed genes
involved in placenta development, such as Plac1 (Cocchia
et al., 2000) (H3015G03: 7.9- and 11.9-fold), Pem
(H3027G05: 9.9- and 11.6-fold), and Adm (H3001H08: 5.6-
and 6.3-fold) (Table 4). The semiquantitative RT-PCR con-
firmed cDNA microarray data for Plac1 (Fig. 4a), but re-
vealed variable expression levels for Pem and Adm genes
(Fig. 4c). It should be pointed out, however, that not all
placenta-specific genes showed marked upregulation in
ES-derived NT placenta. For example, placental lactogen 2
(H3046B04) and placental protein 15 (H3112D04) did not
show any significant differences (data not shown). There-
fore, Plac1 is a candidate for a gene involved in placento-
megaly in ES-derived NT placentas.
This notion is further supported by the expression pat-
terns and map location of Plac1 reported previously (Coc-
chia et al., 2000). Plac1 is located on the X chromosome
(Cocchia et al., 2000), and is thus normally regulated in a
dosage-sensitive manner by methylation. In this study,
however, the donor ES cells are derived from male (XY
karyotype), and therefore, dysregulation is not simply at-
tributable to aberrant activation of a normally inactivated X
chromosome in XX female cells. Previous studies have also
shown appropriate reactivation/inactivation of X chromo-
somes after nuclear transfer of ES (XX karyotype) cells
(Eggan et al., 2000). Therefore, the dysregulation of X
chromosome genes should not be a primary cause of the
placentomegaly in ES-derived NT mice.
Severe placentomegaly, the degree of which is compa-
rable to cloned mouse placenta, has been observed in the
interspecific hybrid mice between female M. spretus (spr)
and male Mus musculus (mus) (Zechner et al., 1996). The
responsible locus (Ihpd) has been mapped to the proximal
region of X chromosome, near the DXMit8 locus at 32.0 cM
(Zechner et al., 1996). The most severe placentomegaly has
been observed in a congenic strain (MH1.5) carrying an
spr-derived genomic region between 3.7 (DXMit54) and 48
cM (DXMit65) on mus background (Hemberger et al., 1999).
It has been proposed that this region contains genes that
promote the overgrowth of placenta. Interestingly, Plac1
has been mapped within this region (Cocchia et al., 2000).
Furthermore, the hypertrophic placentas of interspecific
hybrid mice (Hemberger et al., 1999; Zechner et al., 1996)
showed morphological features similar to the ES-derived
NT placentas described above. In these cases, trophoblast
cells in the spongiotrophoblast layer are enlarged, the clear
demarcation between labyrinth and spongiotrophoblast is
lost, and a large number of endometrial glycogen cells are
distributed within the spongiotrophoblast layer (Hemberger
et al., 1999; Ono et al., 2001; Zechner et al., 1996). It is
interesting to note that Plac1, which was consistently
upregulated in the ES-derived NT placenta, is normally
expressed in labyrinth but not in spongiotrophoblast (Coc-
chia et al., 2000). It may also be relevant that the expression
of Plac1 (Cocchia et al., 2000) in trophoblast cells normally
start immediately after implantation, peaks at midgesta-
tion, and decreases precipitously thereafter. Taken to-
gether, either sustained expression of Plac1 in labyrinthine
trophoblasts until late gestation (e.g., 19.5 dpc) or ectopic
expression of Plac1 in spongiotrophoblast cells could pro-
mote abnormal proliferation of spongiotrophoblast cells
and contribute to placentomegaly in ES-derived NT mice.
New Genes
One of the advantages of using cDNA microarrays that
contain relevant but novel genes is to identify new candi-
date genes for important function in development. New
genes identified in Tables 3 and 4 as potential candidates for
genes directly involved in placentomegaly in NT mice
include the example of clone H3002E07 cDNA, which
showed a great increase in ES-derived NT placenta, and was
thus named Nuclear Transplantation Upregulated Gene 1
(Ntup1). [According to the recommendation by MGI No-
menclature Committee, the gene name was later changed
to Pitrilysin Metalloprotease 1 (Pitrm1) to better reflect its
protein function deduced by the sequence homology de-
scribed below.] Although the sequence of this clone showed
significant similarity to a mouse MGC cDNA clone
(BC006917), the cDNA clones cover only a portion of the
reported transcript. We searched potential full-length
mouse cDNA clones in our 3	-EST collections derived from
the long-insert-enriched cDNA libraries, whose insert size
ranges from 1 to 8 kb with the average 3 to 4 kb (Piao et al.,
2001). Seven cDNA clones matched H3002E07 and were
completely sequenced (GenBank Accession No. AF513714)
(Fig. 5a). The new full sequence provided the previously
unrecovered segment with the ATG start codon in the
mouse MGC cDNA clone (Fig. 5b). Mouse genome se-
quence database (Celera Genomics) contained the gene (ID
mCG1726 [32 kb]) and transcript (ID mCT1034 [3.1 kb]),
and predicts 24 exons (Fig. 5a). Alignment of the Pitrm1
cDNA sequence with mCG1726 and mCT1034 revealed 3
more exons in addition to the 24 predicted ones.
Semiquantitative RT-PCR analysis confirmed the cDNA
microarray data by showing very low expression of this
gene in control 1-cell-derived NT placentas and high ex-
pression in ES-derived NT placentas (Fig. 4d). Searching
against NCBI’s dbEST (Boguski et al., 1993) revealed that
the gene is expressed in more than 30 different tissue types,
with high levels in bone, skin, neural retina, and spleen.
However, no single EST was found in a large collection of
ESTs derived from mature placenta. Although they are
grouped into Unclassified/Others in this database, the ESTs
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TABLE 3
Genes with Reduced Expression in ES-Derived NT Mouse Placenta
Clone
name
Clone’s
GB# Best description Accession No.
Chr.
location
Gene expression
level, 1000
(geometric mean) Fold difference
Cont Cl #1 Cl #2 Cont/Cl #1 Cont/Cl #2
H3129B08 BG086671 Mus musculus H19 fetal liver
mRNA (H19), mRNA
NM_023123.1 7 7806 533 862 14.7 9.1
H3144B07 BG087638 Mus musculus H19 fetal liver
mRNA (H19), mRNA
NM_023123.1 7 6625 619 731 10.7 9.1
H3144B06 BG087637 Mus musculus H19 fetal liver
mRNA (H19), mRNA
NM_023123.1 7 5707 710 784 8.0 7.3
H3144B08 BG075177 UNKNOWN: Similar to Mus
musculus, Similar to zinc
finger protein 220, clone
IMAGE:5360083, mRNA
BC024786.1 500 121 80 4.1 6.2
H3005A04 BG076718 Mus musculus H19 fetal liver
mRNA (H19), mRNA
NM_023123.1 7 3234 790 748 4.1 4.3
H3056D06 BG067621 Mus musculus similar to
hypothetical protein 2 (rRNA
external transcribed spacer) -
mouse (LOC224783), mRNA
XM_128630.1 7110 2181 1580 3.3 4.5
H3003E03 BG063137 Mus musculus, clone IMAGE:
3486529, mRNA
BC032050.1 690 177 196 3.9 3.5
H3079C09 BG069712 Mus musculus similar to
hypothetical protein 2 (rRNA
external transcribed spacer) -
mouse (LOC224783), mRNA
XM_128630.1 679 209 166 3.3 4.1
H3054G10 BG067473 UNKNOWN: Similar to Mus
musculus LOC209870
(LOC209870), mRNA
XM_151373.1 1 1122 359 280 3.1 4.0
H3079C10 BG069713 Mus musculus similar to RIKEN
cDNA 1200011K09
(LOC223704), mRNA
XM_128056.1 15 418 141 105 3.0 4.0
H3050H04 BG080198 Mus musculus similar to
hypothetical protein 2 (rRNA
external transcribed spacer) -
mouse (LOC224783), mRNA
XM_128630.1 2664 921 686 2.9 3.9
H3050H05 BG080199 Mus musculus single-strand
selective monofunctional
uracil DNA glycosylase
(Smug1), mRNA
NM_027885.1 1019 350 265 2.9 3.8
H3129D08 BG086692 Mus musculus DNA segment,
Chr 6, Wayne State University
147, expressed (D6Wsu147e),
mRNA
NM_133345.1 6 736 199 244 3.7 3.0
H3056D07 BG067622 UNKNOWN 9 1195 446 303 2.7 4.0
H3054F09 BG080525 UNKNOWN: Similar to Mus
musculus cyclin ania-6b gene,
partial sequence
AF185591.1 X 2765 947 788 2.9 3.5
H3054F08 BG067459 UNKNOWN: Similar to Mus
musculus X-inactivation
center region; segment 3/3
AJ421480.1 1436 495 412 2.9 3.5
H3056D05 BG067620 UNKNOWN 1620 570 455 2.8 3.6
H3054G08 BG067471 UNKNOWN 5510 2068 1504 2.7 3.7
H3054H08 BG080547 UNKNOWN: Similar to Mus
musculus RIKEN cDNA
1110033009 gene
(1110033009Rik), mRNA
NM_026812.1 7424 2623 2158 2.8 3.4
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TABLE 3—Continued
Clone
name
Clone’s
GB# Best description Accession No.
Chr.
location
Gene expression
level, 1000
(geometric mean) Fold difference
Cont Cl #1 Cl #2 Cont/Cl #1 Cont/Cl #2
H3054H09 BG080548 UNKNOWN: Similar to Homo
sapiens Ena-VASP-like protein
mRNA, complete cds
AF112209.1 13766 4955 3934 2.8 3.5
H3054G11 BG067474 UNKNOWN 1491 584 391 2.6 3.8
H3054G09 BG067472 Mus musculus Btg3-associated
nuclear protein (Banp), mRNA
NM_016812.1 8 4646 1761 1344 2.6 3.5
H3068E10 BG068715 UNKNOWN 2390 861 747 2.8 3.2
H3054E08 BG080512 Mus musculus similar to RIKEN
cDNA 2900026B15 gene
(LOC226598), mRNA
XM_129548.1 1046 411 301 2.6 3.5
H3054H11 BG067486 Mus musculus, Similar to
hypothetical protein from clone
643, clone MGC:7903 IMAGE:
3582955, mRNA, complete cds
BC004728.1 3270 1279 990 2.6 3.3
H3068F11 BG068728 UNKNOWN 1664 616 536 2.7 3.1
H3068F09 BG068726 UNKNOWN 1893 721 642 2.6 3.0
H3054G07 BG080535 Mus musculus LOC230677
(LOC245875), mRNA
XM_149486.1 4238 1747 1350 2.4 3.1
H3054H10 BG080549 Mus musculus, RIKEN cDNA
0610008K04 gene, clone MGC:
25850 IMAGE:4194400, mRNA,
complete cds
BC031854.1 5954 2323 1996 2.6 3.0
H3068E11 BG068716 UNKNOWN 2049 816 676 2.5 3.0
H3017H11 BG077549 Mus musculus similar to CEA-
related cell adhesion molecule 9;
carcinoembryonic antigen 5
(LOC243850), mRNA
XM_145393.1 7 422 137 176 3.1 2.4
H3054H07 BG080546 UNKNOWN: Similar to Homo
sapiens KIAA1798 protein
(KIAA1798), mRNA
XM_027074.2 10 1530 651 494 2.4 3.1
H3054F11 BG080527 Mus musculus ATPase, H
transporting, lysosomal V0
subunit A isoform 4 (Atp6v0a4),
mRNA
NM_080467.1 804 352 261 2.3 3.1
H3128A08 BG073865 UNKNOWN: Similar to Homo
sapiens KIAA1766 protein
(KIAA1766), mRNA
XM_049218.4 1258 464 498 2.7 2.5
H3125A09 BG073718 Mus musculus glutathione
peroxidase 3 (Gpx3), mRNA
NM_008161.1 11 2890 1130 1145 2.6 2.5
H3054E09 BG067448 UNKNOWN 8 538 247 188 2.2 2.9
H3123H11 BG073548 Mus musculus RIKEN cDNA
2900046G09 gene
(2900046G09Rik), mRNA
XM_148130.1 1968 834 765 2.4 2.6
H3054G06 BG067469 UNKNOWN 2407 1114 895 2.2 2.7
Note. All genes listed here show significant and 2-fold differences among control (pooled 1-cell-derived NT placenta), ES-derived NT
placenta #1, and ES-derived NT placenta #2 by 2-way ANOVA (PN  0.05, Bonferroni corrected). For each gene, geometric mean expression
levels were calculated from 3 independent hybridization results. Fold differences were calculated separately for control (Cont) vs cloned
placenta #1 (Cl #1) and control (Cont) vs cloned placenta #2 (Cl #2).
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TABLE 4
Genes with Increased Expression in ES-Derived NT Mouse Placenta
Clone
name
Clone’s
GB# Best description Accession No.
Chr.
location
Gene expression
level, 1000
(geometric mean) Fold difference
Cont Cl #1 Cl #2 Cl #1/Cont Cl #2/Cont
H3037A03 BG079197 Mus musculus actinin, alpha 1 (Actn1),
mRNA
XM_127017.1 109 1683 1925 15.5 17.7
H3087E01 BG070448 Mus musculus annexin A4 (Anxa4),
mRNA
NM_013471.1 6 33 369 480 11.1 14.5
H3104B06 BG084717 Mus musculus, clone IMAGE:3591422,
mRNA
BC007184.1 9 37 397 536 10.7 14.5
H3020H08 BG077954 UNKNOWN: Similar to Mus musculus
RIKEN cDNA 1600019O04 gene
(1600019O04Rik), mRNA
XM_130815.1 3 32 349 391 11.0 12.3
H3028G09 BG065236 Mus musculus, E26 avian leukemia
oncogene 2, 3	 domain, clone MGC:
7318 IMAGE:3486021, mRNA,
complete cds
BC005486.1 16 153 1672 1701 10.9 11.1
H3080B03 BG069786 UNKNOWN: Similar to Rattus
norvegicus 14-3-3 protein beta-
subtype (Ywhab), mRNA
NM_019377.1 54 513 681 9.5 12.7
H3027G05 BG078428 Mus musculus placentae and embryos
oncofetal gene (Pem), mRNA
NM_008818.1 X 133 1321 1543 9.9 11.6
H3094F12 BG071101 Mus musculus, v-ral simian leukemia
viral oncogene homolog B (ras
related), clone MGC: 11937 IMAGE:
3599947, mRNA, complete cds
BC006907.1 89 930 892 10.5 10.1
H3108A12 BG072217 Mus musculus hypothetical protein
DKFZp566A1524 (DKFZp566A1524),
mRNA
NM_144846.1 84 786 915 9.4 10.9
H3108D12 BG072251 Mus musculus hypothetical protein
deleted in polyposis 1 (Dp1), mRNA
NM_007874.1 120 1100 1232 9.2 10.3
H3015G03 BG064121 Mus musculus PLAC1 (Plac1) mRNA,
complete cds
AF234653.1 X 119 941 1421 7.9 11.9
H3106G02 BG084847 UNKNOWN: Similar to Mus musculus
RIKEN cDNA 2810465O16 gene
(2810465O16Rik), mRNA
NM_026055.1 88 768 942 8.7 10.7
H3100D02 BG084395 Mus musculus, clone MGC:11724
IMAGE:3967323, mRNA, complete
cds
BC012401.1 45 432 419 9.6 9.3
H3038B07 BG079300 UNKNOWN 97 855 886 8.9 9.2
H3110F09 BG085262 Mus musculus, clone IMAGE:3586282,
mRNA, partial cds
BC006792.1 82 652 798 8.0 9.8
H3038B03 BG079296 UNKNOWN 12 105 945 903 9.0 8.6
H3042C03 BG079589 Mus musculus adaptor-related protein
complex AP-3, mu 1 subunit
(Ap3m1), mRNA
NM_018829.2 14 92 807 789 8.8 8.6
H3100B08 BG084379 Mus musculus RIKEN cDNA
1110060F11 gene (1110060F11Rik),
mRNA
NM_026395.1 74 595 691 8.0 9.3
H3094A04 BG071035 Mus musculus DnaJ (Hsp40) homolog,
subfamily C, member 3 (Dnajc3),
mRNA
NM_008929.1 101 903 832 9.0 8.3
H3040F11 BG066248 UNKNOWN: Similar to Mus musculus
interferon gamma inducible protein
30 (lfi30), mRNA
NM_023065.1 96 801 838 8.4 8.8
H3036H03 BG079187 Mus musculus vanin 1 (Vnn1), mRNA NM_011704.1 10 68 605 551 8.9 8.1
H3094G12 BG071113 UNKNOWN 59 513 478 8.7 8.1
H3094B04 BG084041 Mus musculus RIKEN cDNA
3110006P09 gene (3110006P09Rik),
mRNA
NM_026521.1 102 779 924 7.6 9.1
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TABLE 4—Continued
Clone
name
Clone’s
GB# Best description Accession No.
Chr.
location
Gene expression
level, 1000
(geometric mean) Fold difference
Cont Cl #1 Cl #2 Cl #1/Cont Cl #2/Cont
H3079B09 BG069700 Mus musculus similar to H4-
K20-specific histone
methyltransferase SET7
(LOC209316), mRNA
XM_132285.1 38 289 338 7.7 9.0
H3070B02 BG081885 Mus musculus vesicle docking
protein, 115 kDa (Vdp-pending),
mRNA
XM_132145.1 33 253 295 7.6 8.9
H3038G07 BG079354 Mus musculus nuclear receptor
co-repressor 2 (Ncor2), mRNA
NM_011424.1 74 568 633 7.6 8.5
H3106E06 BG072080 Mus musculus expressed
sequence AI854545 (AI854545),
mRNA
NM_134064.1 1 68 497 601 7.3 8.9
H3064F05 BG068360 Mus musculus SWI/SNF related,
matrix associated, actin
dependent regulator of
chromatin, subfamily 1,
member 1 (Smarcf1), mRNA
NM_033566.1 4 49 426 356 8.8 7.3
H3108E12 BG072263 Mus musculus myeloid cell
leukemia sequence 1 (Mcl1),
mRNA
NM_008562.1 3 84 603 715 7.2 8.5
H3094D02 BG071068 Rattus norvegicus Guanine
nucleotide-binding protein beta
1 (Gnb1), mRNA
NM_030987.1 4 44 333 349 7.6 8.0
H3002E07 BG062964 Mus musculus Pitrilysin
metalloproteinase 1 (Pitrm1)
mRNA, complete cds
AF513714.1 141 1037 1171 7.4 8.3
H3108A02 BG085042 Mus musculus, RIKEN cDNA
4833427E09 gene, clone MGC:
37536 IMAGE:4986725, mRNA,
complete cds
BC031172.1 14 43 305 365 7.1 8.5
H3030A07 BG065345 Mus musculus similar to p21
(CDKN1A)-activated kinase 2
(LOC224105), mRNA
XM_148586.1 16 80 599 634 7.5 7.9
H3027E01 BG065110 Mus musculus H2A histone
family, member Z (H2afz),
mRNA
NM_016750.1 112 807 907 7.2 8.1
H3106G12 BG072107 UNKNOWN: Similar to Homo
sapiens muscleblind-like
protein MBLL39 (MBLL39)
transcript variant 1, mRNA
NM_144778.1 14 78 494 701 6.4 9.0
H3108B12 BG072229 Mouse gene for spot35/
calbindin-D28k, exon 10–11
D26352.1 4 79 575 629 7.3 7.9
H3144G12 BG075228 Mus musculus glypican 1
(Gpc1), mRNA
NM_016696.1 110 666 1036 6.1 9.4
H3038D12 BG079328 Mus musculus expressed
sequence C77892 (C77892),
mRNA
XM_129496.1 1 51 348 420 6.9 8.3
H3036C03 BG079139 UNKNOWN: Similar to Mus
musculus RNA polymerase II 1
(Rpo2-1), mRNA
XM_126415.1 11 65 495 484 7.6 7.5
H3023C04 BG078066 UNKNOWN: Similar to Mus
musculus intergral membrane
protein 1 (ltm1), mRNA
NM_008408.1 9 290 1969 2371 6.8 8.2
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TABLE 4—Continued
Clone
name
Clone’s
GB# Best description Accession No.
Chr.
location
Gene expression
level, 1000
(geometric mean) Fold difference
Cont Cl #1 Cl #2 Cl #1/Cont Cl #2/Cont
H3018E09 BG077689 UNKNOWN: Similar to Mus
musculus actinin, alpha 1
(Actn1), mRNA
XM_127017.1 71 504 545 7.1 7.7
H3098D02 BG084265 Mus musculus protein lyrosine
phosphatase, receptor-type, F
interacting protein, binding
protein 2 (Pptibp2), mRNA
NM_008905.1 63 458 464 7.3 7.4
H3044A03 BG066603 Mus musculus cartilage
associated protein (Crtap),
mRNA
NM_019922.1 9 407 2750 3139 6.8 7.7
H3092B11 BG070959 Mus musculus Ral-interacting
protein 1 (Rip1), mRNA
NM_009067.1 17 39 248 323 6.3 8.2
H3032A03 BG078791 Mus musculus mitogen-
activated protein kinase kinase
kinase 7 interacting protein 2
(Map3k7ip2), mRNA
NM_138667.1 88 616 629 7.0 7.2
H3026G05 BG078337 Mus musculus tumor rejection
antigen gp96 (Tra1), mRNA
NM_011631.1 10 711 5040 4935 7.1 6.9
H3149F03 BG088178 Mus musculus RIKEN cDNA
1200007E24 gene
(1200007E24Rik), mRNA
XM_133801.1 52 334 399 6.4 7.7
H3041A05 BG066272 UNKNOWN 37 243 270 6.6 7.3
H3023C02 BG064730 Mus musculus neural precursor
cell expressed, developmentally
down-regulated gene 1 (Nedd1),
mRNA
NM_008682.1 92 532 763 5.8 8.3
H3038D07 BG079323 Mus musculus RIKEN cDNA
2310009M24 gene
(2310009M24Rik), mRNA
NM_080638.1 84 513 642 6.1 7.7
H3074G02 BG082304 Mus musculus, Similar to
mitogen activated protein
kinase 1, clone MGC:7948
IMAGE:3584356, mRNA,
complete cds
BC006708.1 16 42 301 281 7.1 6.6
H3099D09 BG084334 UNKNOWN: Similar to Mus
musculus similar to mitogen-
activated protein kinase kinase
kinase kinase 4; NCK
interacting kinase; HPK/GCK-
like kinase (LOC226992),
mRNA
XM_129778.1 1 95 646 642 6.8 6.8
H3098H06 AU041226 Mus musculus TAF 10 RNA
polymerase II, TATA box
binding protein (TBP)-associated
factor, 30 kDa (Taf10), mRNA
NM_020024.1 10 172 1176 1163 6.8 6.8
H3031H05 BG065504 Mus musculus similar to SWI/
SNF related, matrix associated,
actin dependent regulator of
chromatin, subfamily a,
member 3 (LOC215776), mRNA
XM_125500.1 227 1506 1565 6.6 6.9
H3071B05 BG068956 Mus musculus RIKEN cDNA
1200009K13 gene
(1200009K13Rik), mRNA
NM_025814.1 111 724 778 6.5 7.0
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TABLE 4—Continued
Clone
name
Clone’s
GB# Best description Accession No.
Chr.
location
Gene expression
level, 1000
(geometric mean) Fold difference
Cont Cl #1 Cl #2 Cl #1/Cont Cl #2/Cont
H3005G09 BG063323 Mus musculus growth factor
receptor bound protein 2-
associated protein 1 (Gab1),
mRNA
XM_134516.1 42 293 268 7.0 6.4
H3026G03 BG065043 Mus musculus importin beta
(lmprb), mRNA
NM_008379.1 11 99 674 645 6.8 6.5
H3105E11 BG072000 Mus musculus, RIKEN cDNA
2610306D21 gene, clone
IMAGE:1224918, mRNA
BC030677.1 48 306 328 6.4 6.8
H3033G01 BG078928 Mus musculus Scgn10 like-
protein (Sclip), mRNA
NM_009133.1 61 344 456 5.7 7.5
H3138E02 BG087341 Mouse mRNA for collagen
alpha-2(IV) chain
X04647.1 8 595 3311 4552 5.6 7.6
H3109F03 BG085191 Mus musculus v-crk-associated
tyrosine kinase substrate
(Crkas), mRNA
NM_009954.1 133 786 947 5.9 7.1
H3014D05 BG077365 Mus musculus, Similar to
calnexin, clone MGC:7708
IMAGE:3497769, mRNA,
complete cds
BC012408.1 63 392 419 6.3 6.7
H3096A12 BG084094 UNKNOWN: Similar to Mouse
MHC class I H-2 (q-haplotype)
classical transplantation antigen
mRNA, 3	 non-coding regions 1
and 2
M19687.1 17 801 4867 5399 6.1 6.7
H3022D10 BG064661 Mus musculus similar to 22
kDa neuronal tissue-enriched
acidic protein (Basp1), mRNA
XM_127954.1 177 986 1260 5.6 7.1
H3038G03 BG079350 Mus musculus RIKEN cDNA
2610020P18 gene
(2610020P18Rik), mRNA
NM_023294.1 50 300 320 6.0 6.4
H3025E03 BG064932 Mus musculus nucleolin (Ncl),
mRNA
NM_010880.1 1 192 1178 1200 6.1 6.3
H3102G04 BG084591 Mus musculus RIKEN cDNA
1500001M02 gene
(1500001M02Rik), mRNA
XM_128788.1 1588 9618 10049 6.1 6.3
H3044G05 BG066672 UNKNOWN 111 726 626 6.5 5.6
H3102E12 BG071734 Mus musculus B-cell receptor-
associated protein 37 (Bcap37),
mRNA
NM_007531.1 6 82 496 502 6.0 6.1
H3102C12 BG071712 Mus musculus ADP-
ribosylation-like factor 6
interacting protein (Arl6ip),
mRNA
XM_133792.1 69 384 445 5.6 6.4
H3098A08 BG084240 Mus musculus RIKEN cDNA
1010001M04 gene
(1010001M04Rik), mRNA
NM_029272.1 115 695 681 6.0 5.9
H3001H08 BG063079 Mus musculus adrenomedullin
(Adm), mRNA
NM_009627.1 7 65 360 411 5.6 6.3
H3105F07 BG072007 Mus musculus similar to dynein
light chain-A (LOC235661),
mRNA
XM_135222.1 43 237 269 5.6 6.3
H3040A03 BG079454 Mus musculus adaptor-related
protein complex AP-3, beta 1
subunit (Ap3b1), mRNA
NM_009680.2 13 98 564 588 5.8 6.0
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Clone
name
Clone’s
GB# Best description Accession No.
Chr.
location
Gene expression
level, 1000
(geometric mean) Fold difference
Cont Cl #1 Cl #2 Cl #1/Cont Cl #2/Cont
H3110H12 BG072476 Mus musculus eukaryotic
translation initiation factor 3,
subunit 4 (delta, 44 kDa)
(Eif3s4), mRNA
NM_016876.1 154 888 928 5.8 6.0
H3039G05 BG066172 UNKNOWN: Similar to Mus
musculus erythroid
differentiation regulator (edr),
mRNA
NM_133362.1 407 2193 2596 5.4 6.4
H3110H10 BG072474 UNKNOWN 96 516 603 5.4 6.3
H3159G06 BG088953 UNKNOWN: Similar to Mus
musculus procollagen, type IV,
alpha 1 (Col4a1), mRNA
XM_134042.1 8 644 3232 4330 5.0 6.7
H3109C02 BG085154 Mus musculus tissue inhibitor
of metalloproteinase 3 (Timp3),
mRNA
NM_011595.1 10 198 954 1376 4.8 7.0
H3024E01 BG064843 Mus musculus similar to
phosphatidylinositol binding
clat assembly protein
(LOC233489), mRNA
XM_133617.1 91 506 543 5.6 6.0
H3028B11 BG078470 Mus musculus RNA binding
motif, single stranded
interacting protein 1 (Rbms1),
mRNA
XM_130340.1 144 791 866 5.5 6.0
H3109C03 BG085155 Mus musculus glucosidase,
alpha, acid (Gaa), mRNA
NM_008064.1 11 219 1099 1430 5.0 6.5
H3102G06 BG071748 Mus musculus RIKEN cDNA
6720465F12 gene
(6720465F12Rik), mRNA
NM_133777.1 138 700 890 5.1 6.4
H3034A11 BG065687 UNKNOWN: Similar to Homo
sapiens serine/threonine kinase
24 (STE20 homolog, yeast)
(STK24), mRNA
XM_053212.3 14 199 1124 1140 5.7 5.7
H3020C04 BG077897 UNKNOWN: Similar to Homo
sapiens mRNA for KIAA1721
protein, partial cds
AB051508.1 44 238 260 5.4 6.0
H3027E07 BG078408 Mus musculus enolase 1, alpha
non-neuron (Eno1), mRNA
NM_023119.1 4 172 929 1006 5.4 5.9
H3025D01 BG064920 Mus musculus reduced
expression 3 (Rex3), mRNA
NM_009052.1 X 560 2970 3301 5.3 5.9
H3108C12 BG072241 UNKNOWN 234 1182 1438 5.1 6.2
H3032A05 BG065515 UNKNOWN: Similar to Mus
musculus similar to
transcription factor (p38
interacting protein)
(LOC212521), mRNA
XM_130880.1 86 416 549 4.9 6.4
H3104E08 BG071910 Mus musculus similar to
hypothetical protein MGC12981
(2310061109Rik), mRNA
XM_129811.1 155 854 859 5.5 5.6
H3038D05 BG079321 Mus musculus RIKEN cDNA
2310009M24 gene
(2310009M24Rik), mRNA
NM_080638.1 166 858 985 5.2 5.9
Note. All genes listed here show significant differences among control, cloned mouse #1 and #2 by two-way ANOVA (PN  0.05,
Bonferroni corrected). For each gene, geometric mean expression levels were calculated from three independent hybridization results. Fold
differences were calculated separately for control (Cont) vs cloned placenta #1 (Cl #1) and control (Cont) vs cloned placenta #2 (Cl #2).
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that we have generated from 7.5-dpc ectoplacental cone
include 3 that correspond to this gene out of 3000 se-
quenced. Therefore, the gene is expressed at low level in
early placenta, but is essentially none in mature placenta.
Thus, Pitrm1, which is normally expressed in actively
remodeling tissues such as bone, is abnormally upregulated
in ES-derived NT placentas.
Homology searches against public protein databases re-
vealed a strong match to human pitrilysin metalloprotease
1 (Fig. 5b). Therefore, this new gene is very likely a new
member of metalloprotease gene family, and may thus be
involved in tissue remodeling. Taken together, the dra-
matic upregulation of Pitrm1 in ES-derived NT placenta,
combined with its putative metalloprotease character,
makes it a possible candidate for a gene directly involved in
the invasive growth of the spongiotrophoblast layer, leading
to the loss of a clear demarcation between labyrinth and
spongiotrophoblast layers.
Two Types of Placentomegaly
In general, it is difficult to draw general conclusions
because analyses of NT animals have been done on the rare
embryos or placentas that successfully survive. Here, too,
the number of NT placenta is limited, but a number of
genes showed consistent and suggestive results.
Because placentomegaly is often associated with abnor-
mal expression of imprinted genes, imprinted genes were
initially proposed as causative of aberrations (Wakayama
and Yanagimachi, 1999). In the cases of NT derived from ES
cells as donor nucleus, epigenetic instability of imprinted
genes in ES cells and ES-derived NT placentas and embryos
is well established (Humpherys et al., 2001), but there is no
convincing correlation between the size of placenta and the
expression levels of any imprinted genes. Furthermore, NT
embryos and placentas derived from cumulus cells show no
epigenetic instability or individual-to-individual variability
for imprinted genes (Inoue et al., 2002), but epigenetically
stable fibroblast cells, once they were used as nuclear
donor, lead to placentomegaly. Therefore, genes other than
imprinted genes should cause placentomegaly.
Based on histology, we infer that it may be useful in
further studies of etiology to differentiate between two
types of placentomegaly, tentatively called here Type I and
Type II, and we have characterized them as follows.
Type I features relatively normal structures, with the
enlargement of the labyrinth trophoblast layer. This seems
to occur when the IGF-related growth regulatory pathways
are affected. The knockout mice of an imprinted gene H19
promote the growth of placenta by activating a neighboring
imprinted gene Igf2 (Eggenschwiler et al., 1997; Leighton et
al., 1995). Mice disrupted in Gpc3, a causative gene for
Simpson–Golabi–Behmel syndrome, show a similar placen-
tomegaly, and are implicated to be involved in an IGF-
related growth regulatory pathway, though the actual func-
tion of the protein is still not known (Chiao et al., 2002).
Type I would thus be especially influenced by genomic
imprinting mechanisms.
Type II features disorganized structure, with the loss of
demarcation between spongiotrophoblast layer and laby-
rinth layer, and with an accompanying expansion of the
spongiotrophoblast layer. Based on our own and published
results, the placentomegaly associated with NT always falls
into this type. Placentomegaly in interspecific backcross
mice also falls into this category (Hemberger et al., 1999;
Zechner et al., 1996). Although the genetic pathway leading
to this type of placentomegaly remains to be elucidated, the
results point to Plac1 and Pitrm1 as possible effector genes.
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